Literature DB >> 9834233

Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping.

J R Sawyer1, J L Lukacs, N Munshi, K R Desikan, S Singhal, J Mehta, D Siegel, J Shaughnessy, B Barlogie.   

Abstract

Multicolor spectral karyotyping (SKY) was performed on bone marrow samples from 50 patients with multiple myeloma (MM) in anticipation of discovering new previously unidentified translocations. All samples showed complex karyotypes with chromosome aberrations which, in most cases, were not fully characterized by G-banding. Patients of special interest were those who showed add(14)(q32), add(8)(q24) and those whose G-banding karyotypes showed poor chromosome morphology. Three new recurring chromosome translocations not previously reported in MM were identified. Two of the translocations involve recurring aberrations at band 14q32.3, the site of the IgH locus, with different exchange partners. The most frequently recurring rearrangement was a subtle translocation at 14q32.3 designated as a t(14;16)(q32;q22 approximately 23), which was identified in six patients. A second and larger translocation at 14q32, identified in two patients, was designated as a t(9;14)(p13;q32), previously associated with Waldenstrom's macroglobulinemia and lymphoplasmacytoid lymphoma. A third translocation, identified in two patients, involved a whole-arm t(6;8)(p10;q10) translocation. The SKY technique was able to refine the designations of over 156 aberrations not fully characterized by G-banding in this study and resolved additional chromosome aberrations in every patient studied except two. The t(14;16)(q32;q22 approximately 23) identified by SKY in this study suggests this may be a frequent translocation in MM associated with complex karyotypes and disease progression. Therefore, the SKY technique provides a useful adjunct to routine G-banding and fluorescence in situ hybridization studies in the cytogenetic analysis of MM.

Entities:  

Mesh:

Year:  1998        PMID: 9834233

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Limitations of chromosome classification by multicolor karyotyping.

Authors:  C Lee; D Gisselsson; C Jin; A Nordgren; D O Ferguson; E Blennow; J A Fletcher; C C Morton
Journal:  Am J Hum Genet       Date:  2001-02-19       Impact factor: 11.025

2.  Epstein-Barr virus-positive diffuse large B-cell lymphoma carrying a t(9;14)(p13;q32) translocation.

Authors:  Hitoshi Ohno; Momoko Nishikori; Hironori Haga; Kotaro Isoda
Journal:  Int J Hematol       Date:  2009-05-12       Impact factor: 2.490

3.  Thirty patients with primary plasma cell leukemia: a single center experience.

Authors:  Milica Colović; Gradimir Janković; Nada Suvajdzić; Natasa Milić; Vesna Dordević; Snezana Janković
Journal:  Med Oncol       Date:  2007-10-10       Impact factor: 3.064

4.  Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma.

Authors:  Y Shou; M L Martelli; A Gabrea; Y Qi; L A Brents; A Roschke; G Dewald; I R Kirsch; P L Bergsagel; W M Kuehl
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

5.  Genes with a spike expression are clustered in chromosome (sub)bands and spike (sub)bands have a powerful prognostic value in patients with multiple myeloma.

Authors:  Alboukadel Kassambara; Dirk Hose; Jérôme Moreaux; Brian A Walker; Alexei Protopopov; Thierry Reme; Franck Pellestor; Véronique Pantesco; Anna Jauch; Gareth Morgan; Hartmut Goldschmidt; Bernard Klein
Journal:  Haematologica       Date:  2011-11-18       Impact factor: 9.941

6.  Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma.

Authors:  J R Sawyer; E Tian; J D Shaughnessy; J Epstein; C M Swanson; C Stangeby; C L Hale; L Parr; M Lynn; G Sammartino; J L Lukacs; C Stein; C Bailey; M Zangari; F E Davies; F Van Rhee; B Barlogie; G J Morgan
Journal:  Leukemia       Date:  2016-10-03       Impact factor: 11.528

Review 7.  WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.

Authors:  C Marcelo Aldaz; Brent W Ferguson; Martin C Abba
Journal:  Biochim Biophys Acta       Date:  2014-06-14

8.  Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors.

Authors:  Ana Gabrea; Maria Luisa Martelli; Ying Qi; Anna Roschke; Bart Barlogie; John D Shaughnessy; Jeffrey R Sawyer; W Michael Kuehl
Journal:  Genes Chromosomes Cancer       Date:  2008-07       Impact factor: 5.006

9.  Allelic mutations in noncoding genomic sequences construct novel transcription factor binding sites that promote gene overexpression.

Authors:  Erming Tian; Magne Børset; Jeffrey R Sawyer; Gaute Brede; Thea K Våtsveen; Håkon Hov; Anders Waage; Bart Barlogie; John D Shaughnessy; Joshua Epstein; Anders Sundan
Journal:  Genes Chromosomes Cancer       Date:  2015-07-29       Impact factor: 5.006

Review 10.  Genetic events in the pathogenesis of multiple myeloma.

Authors:  W J Chng; O Glebov; P L Bergsagel; W M Kuehl
Journal:  Best Pract Res Clin Haematol       Date:  2007-12       Impact factor: 3.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.